ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1–Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results

Heather A. Wakelee, Jyoti D. Patel, Rebecca Suk Heist et al. · Journal of Thoracic Oncology · 2016

Cited by 15 works. doi:10.1016/j.jtho.2016.09.009 Open-access PDF

Authors